BSECompany Update12 Aug 2026 · 12 Aug 2026, 08:03 pm

Please find enclosed herewith the outcome of Members of the Nomination and Remuneration Committee of Bliss GVS Pharma Limited ("the Company")in its meeting held today i.e. on August 12, ....

Bliss GVS Pharma Ltd · 506197

✦ AI Summary

Bliss GVS Pharma Ltd granted 3,20,000 stock options under Employee Stock Options Plan 2019 to eligible employees, with vesting in 4 instalments over 48 months, and a lock-in period of 6 months from allotment of equity shares.

Analysis Scores

Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact8/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Bliss GVS Pharma Ltd - 506197 - Grant Of Options Under Bliss GVS Pharma Limited - Employee Stock Options Plan 2019

Attachments (1)

📄

733accd5-ec86-464e-9891-a80b686bbfef.pdf

pdf

Download →
View document text
August 12, 2026 To To The Manager, Listing Department The General Manager, Listing Department National Stock Exchange of India Ltd. BSE Limited Plot no. C/1 G Block, Phiroze Jeejeebhoy Towers, Bandra-Kurla Complex, Bandra (East), Dalal Street, Mumbai- 400 051 Mumbai- 400 001 Symbol: BLISSGVS Scrip Code: 506197 Dear Sir/Madam, Subject: Grant of Options under Bliss GVS Pharma Limited – Employee Stock Options Plan 2019 Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('SEBI Listing Regulations') read with Schedule III of SEBI Listing Regulations, we would like to inform you that, the Members of the Nomination and Remuneration Committee of Bliss GVS Pharma Limited (“the Company”) in its meeting held today i.e. on August 12, 2026 has granted 3,20,000 (Three Lakh Twenty Thousand) Stock Options under Bliss GVS Pharma Limited– Employee Stock Options Plan 2019 to the eligible employees of the Company. Required details under SEBI Master Circular No. HO/49/14/14(7)2025-CFD- POD2/I/3762/2026 dated January 30, 2026, read with SEBI Circular SEBI/HO/CFD/CFD- PoD-1/P/CIR/2023/123 dated July 13, 2023, is enclosed. You are requested to take the aforementioned information for your records. Thanking you. Yours faithfully, For Bliss GVS Pharma Limited Aditi Bhatt Company Secretary End: a/a Sr. No. Particulars Details a) Brief Details of Options Granted 3,20,000 (Three Lakh Twenty Thousand) Stock Options were granted under Bliss GVS Pharma Limited – Employee Stock Options Plan 2019 by the Nomination and Remuneration Committee. b) Whether the scheme is in terms of Yes SEBI (SBEB) Regulations, 2014/ SEBI (SBEBSE) Regulations, 2021 (if applicable) c) Total number of shares covered by 3,20,000 (Three Lakh Twenty these options Thousand) equity shares of Re. 1/- each (Each stock option is convertible into the equivalent number of shares of the face value of Re. 1/- each). d) Pricing formula Exercise Price of Rs. 43/- per option/per share based upon the BSE Last Closing Market price dated August 11, 2026, after deducting 91.32% discount and as determined by the Members of the Nomination and Remuneration Committee to bring uniformity in the exercise price of earlier options granted by the Company. e) Options Vested Not Applicable f) Time within which option may be The vested options shall be exercisable exercised within a period of 6 months from the date of vesting of such options. g) Options exercised Not Applicable h) Money realized by exercise of Not Applicable options i) The total number of shares arising Not Applicable as a result of exercise of option j) Options lapsed Not Applicable k) Variation of terms of options Not Applicable l) Brief details of significant terms i) The Options granted would Vest in to the Eligible Employee in 4 (four) instalments in the following manner: a) 25% of the total number of Options granted after 12 months, from the date of Grant of Options. b) 25% of the total number of Options granted after 24 months, from the date of Grant of Options. c) 25% of the total number of Options granted after 36 months, from the date of Grant of Options. d) 25% of the total number of Options granted after 48 months, from the date of Grant of Options e) There shall be a minimum period of one year between the grant of options and vesting of options. f) The maximum exercise period for Exercise of an Option would be six months from the date of its Vesting. g) The Equity Shares arising out of Vested Options under the scheme, shall be subject to lock-in for a period of 6 (six) months from the date of allotment of Equity Shares. m) Subsequent changes or Not Applicable cancellation or exercise of such options n) Subsequent changes or Not Applicable cancellation or exercise of such options